Picture of Marinus Pharmaceuticals logo

MRNS — Marinus Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Marinus Pharmaceuticals Reports Second Quarter 2022 Financial Results

Aug 11 (Reuters) - Marinus Pharmaceuticals Inc  MRNS.O :
    * MARINUS PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND
REPORTS
SECOND QUARTER 2022 FINANCIAL RESULTS
    * MARINUS PHARMACEUTICALS INC - FOR FISCAL YEAR 2022,
COMPANY
EXPECTS BARDA REVENUES IN RANGE OF $7 TO $10 MILLION
    * MARINUS PHARMACEUTICALS - RECOGNIZED $1.8 MILLION IN TOTAL
REVENUE FOR THREE MONTHS ENDED JUNE 30, 2022
    * MARINUS PHARMACEUTICALS INC QTRLY NET LOSS PER SHARE OF
COMMON
STOCK-BASIC AND DILUTED $1.06

Source text for Eikon:  ID:nBw8HqkNGa 
Further company coverage:  MRNS.O 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Marinus Pharmaceuticals

See all news